Author: CSN
Obstacles to open: Nevada cannabis consumption lounges face hurdles despite legalization
Years after cannabis consumption lounges were legalized in Nevada, only one operates regularly for public use statewide.
Retail marijuana market likely coming to Virginia following election
With Democrat Abigail Spanberger being elected as Virginia’s Governor and Democrats in control of both houses of the General Assembly,…
Curaleaf Holdings Shares Fell After Earnings, But It Leads The Cannabis Pack
Explore Curaleaf Holdings, Inc.’s earnings, market outlook, and upside tied to U.S. cannabis legalization. Click to see if CURLF stock…
Legalize Marijuana To Fund Broadband Access Expansion, Wisconsin Democratic Candidates For Governor Say
With a year to go until Wisconsin voters are set to elect their next governor, the majority of the current…
Canopy Growth outlines path to improved margins and cash flow with Canadian cannabis momentum
Q2 2026 Management View CEO Luc Mongeau highlighted “continued momentum in our Canadian adult-use cannabis business, consistent growth in our…
Cannabis Stock Tilray Brands Skyrockets 94.5%: Time to Buy, Sell or Hold?
In the past three months, shares of Tilray Brands TLRY have skyrocketed 94.5%, significantly outperforming the industry’s 2.5% decline. Image…
Marijuana lounges are about to become a reality in Massachusetts. Here’s what they could look like.
State officials are slated to take a final vote Friday on rolling out social consumption licenses, which would create spaces…
Marijuana lounges are about to become a reality in Massachusetts. Here’s what they will look like.
State officials are slated to take a final vote Friday on rolling out social consumption licenses, which would create spaces…
Illinois forbids outdoor cannabis farms. A giant weed company wants to change that.
Illinois doesn’t allow cannabis to be grown outdoors. A legal challenge from a cannabis giant could change that —and give…
Aurora Cannabis: Upgrading On High-Margin Medical Cannabis Sales Growth – Buy
Aurora Cannabis Inc. is rated a Buy with 40% upside in current levels and expects solid growth in medical cannabis…
Recent Comments